China / Hong Kong Company Focus China Vanke Bloomberg: 2202 HK Equity | 000002 CH Equity | Reuters: 2202.HK | 000002.SZ Refer to important disclosures at the end of this report DBS Group Research . Equity 6 January 2016 H: HOLD (Downgrade from BUY) Shareholding uncertainty overshadows Last Traded Price (H): HK$20.80 (CSI300 Index : 3,540) strong fundamentals Price Target (H): HK$19.60 (6% downside) (Prev HK$23.41) Better-than-expected sales/acquisitions in Dec 2015 will likely lead to decent sales growth in 2016 A: BUY (Under review) Yet, shareholding structure is unlikely to improve in the near Last Traded Price (A): RMB24.43 (HSI : 20,981) term and potential asset restructuring is uncertain Price Target (A): RMB19.31 (21% downside) Shareholding competition will likely distract management Potential Catalyst: Better-than-expected shareholding structure efforts and affect Vanke’s long-term strategy Where we differ: Our FY15-17F EPS are below consensus Share price is under pressure after trading resumption; Analyst Downgrade Vanke-H from BUY to HOLD Ken HE CFA, +86 21 6888 3375 Uncertainty in potential asset restructuring (Details on page 3). The
[email protected] difficulties are in: (i) identifying potential acquisition targets to fall in Carol WU +852 2863 8841 the definition of “material asset restructuring”, and to improve
[email protected] shareholding structure (or mitigate Baoneng’s influence in Vanke’s Danielle WANG CFA, +852 2820 4915 board/strategy), as well as to strengthen Vanke’s traditional
[email protected] residential and new business lines; and (ii) obtaining shareholders’ Andy YEE CFA, +852 2971 1773 approval given current shareholding structure and rich valuation.